Stay updated on Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The Study Details page for NCT03879057 remains the same across screenshots, with no updates to design, criteria, or endpoints; any variations are limited to layout or wording.
    Difference
    0.5%
    Check dated 2025-11-03T20:53:03.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Major update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T05:16:14.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Upgrade version from v3.0.2 to v3.1.0 and add a contact/identifier (linshenpku@163.com and 86-10-88196561); remove the old version reference.
    Difference
    0.1%
    Check dated 2025-09-29T03:00:13.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the 'Back to Top' link/button was removed. This is a minor maintenance change with no impact on core content, pricing, stock, or time slots.
    Difference
    0.2%
    Check dated 2025-09-14T19:01:06.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T14:27:49.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically emphasizing the Beijing Municipality and the drug surufatinib, while removing several previous location references and drug information.
    Difference
    2%
    Check dated 2025-08-31T11:44:44.000Z thumbnail image

Stay in the know with updates to Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib & JS001 Combo in Advanced Solid Tumors Clinical Trial page.